ArticleCureus2026
Robotic Adrenalectomy: A Portuguese National Health Service Experience.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMinimally invasive adrenalectomy is currently the gold-standard approach for the surgical management of benign adrenal disease. In recent years, robotic-assisted adrenalectomy has gained increasing acceptance, offering technical advantages that may be particularly relevant in complex cases. The implementation of an endocrine robotic surgery program in a public hospital presents specific organizational and technical challenges.
methodsWe report a consecutive series of robotic transabdominal adrenalectomies performed at a tertiary, university-affiliated public hospital between April 2024 and December 2025. Demographic, perioperative, and postoperative outcomes were retrospectively analyzed.
resultsThirty-two robotic adrenalectomies were performed (17 right-sided, 15 left-sided). The mean adrenal gland diameter was 6.2 cm, with a mean tumor diameter of 3.0 cm. Mean operative time was 110 minutes. Conversion to open surgery occurred in one patient (3%). Overall morbidity was 9.4%, including one pancreatic fistula and one incisional hernia requiring reoperation. There was no mortality. The mean hospital stay was 1.2 days. DISCUSSION: Our perioperative outcomes are comparable to those reported in the literature. Robotic adrenalectomy provides excellent visualization, enhanced dexterity, and ergonomic benefits, which may facilitate dissection in anatomically demanding situations. Emerging evidence suggests a potential role for robotic platforms in large, malignant, or technically complex adrenal tumors traditionally excluded from minimally invasive surgery.
conclusionRobotic adrenalectomy is a safe and feasible technique when implemented in specialized centers by experienced surgical teams. Its role may extend beyond benign disease to selected complex adrenal cases, although further studies are required to define its indications and cost-effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.